Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Renal dysfunction, restrictive left ventricular filling pattern and mortality risk in patients admitted with heart failure: a 7-year follow-up study

Authors: Morten Schou, Jesper Kjaergaard, Christian Torp-Pedersen, Christian Hassager, Finn Gustafsson, Dilek Akkan, Jacob E Moller, Lars Kober

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Renal dysfunction is associated with a variety of cardiac alterations including left ventricular (LV) hypertrophy, LV dilation, and reduction in systolic and diastolic function. It is common and associated with an increased mortality risk in heart failure (HF) patients. This study was designed to evaluate whether severe diastolic dysfunction contribute to the increased mortality risk observed in HF patients with renal dysfunction.

Methods

Using Cox Proportional Hazard Models on data (N = 669) from the EchoCardiography and Heart Outcome Study (ECHOS) study we evaluated whether estimated glomerular filtration rate (eGFR) was associated with mortality risk before and after adjustment for severe diastolic dysfunction. Severe diastolic dysfunction was defined by a restrictive left ventricular filling pattern (RF) (=deceleration time < 140 ms) by Doppler echocardiography.

Results

Median eGFR was 58 ml/min/1.73 m2, left ventricular ejection fraction was 33% and RF was observed in 48%. During the 7 year follow up period 432 patients died. Multivariable adjusted eGFR was associated with similar mortality risk before (Hazard Ratio(HR)eGFR 10 ml increase: 0.94 (95% CI: 0.89-0.99, P = 0.024) and after (HReGFR 10 ml increase: 0.93 (0.89-0.99), P = 0.012) adjustment for RF (HR: 1.57 (1.28-1.93), P < 0.001).

Conclusions

In patients admitted with HF RF does not contribute to the increased mortality risk observed in patients with a decreased eGFR. Factors other than severe diastolic dysfunction may explain the association between renal function and mortality risk in HF patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hillege HL, Girbes AR, de Kam PJ, et al: Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000, 102: 203-210. 10.1161/01.CIR.102.2.203.CrossRefPubMed Hillege HL, Girbes AR, de Kam PJ, et al: Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000, 102: 203-210. 10.1161/01.CIR.102.2.203.CrossRefPubMed
2.
go back to reference Hillege HL, Nitsch D, Pfeffer MA, Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators, et al: Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006, 113: 671-678. 10.1161/CIRCULATIONAHA.105.580506.CrossRefPubMed Hillege HL, Nitsch D, Pfeffer MA, Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators, et al: Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006, 113: 671-678. 10.1161/CIRCULATIONAHA.105.580506.CrossRefPubMed
3.
go back to reference de Silva R, Nikitin NP, Witte KK, et al: Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J. 2006, 27: 569-581. 10.1093/eurheartj/ehi696.CrossRefPubMed de Silva R, Nikitin NP, Witte KK, et al: Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J. 2006, 27: 569-581. 10.1093/eurheartj/ehi696.CrossRefPubMed
4.
go back to reference Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW: The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000, 35: 681-689. 10.1016/S0735-1097(99)00608-7.CrossRefPubMed Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW: The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000, 35: 681-689. 10.1016/S0735-1097(99)00608-7.CrossRefPubMed
5.
go back to reference Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J, ADHERE Scientific Advisory Committee and Investigators: High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007, 6: 422-430.CrossRef Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J, ADHERE Scientific Advisory Committee and Investigators: High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007, 6: 422-430.CrossRef
6.
go back to reference Ahmed A, Rich MW, Sanders PW, et al: Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol. 2007, 99: 393-398. 10.1016/j.amjcard.2006.08.042.CrossRefPubMed Ahmed A, Rich MW, Sanders PW, et al: Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol. 2007, 99: 393-398. 10.1016/j.amjcard.2006.08.042.CrossRefPubMed
7.
go back to reference de Silva R, Nikitin NP, Bhandari S, Nicholson A, Clark AL, Cleland JG: Atherosclerotic renovascular disease in chronic heart failure: should we intervene?. Eur Heart J. 2005, 26: 1596-1605. 10.1093/eurheartj/ehi304.CrossRefPubMed de Silva R, Nikitin NP, Bhandari S, Nicholson A, Clark AL, Cleland JG: Atherosclerotic renovascular disease in chronic heart failure: should we intervene?. Eur Heart J. 2005, 26: 1596-1605. 10.1093/eurheartj/ehi304.CrossRefPubMed
8.
go back to reference Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P: Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?. J Am Coll Cardiol. 2003, 41: 105-112.CrossRefPubMed Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P: Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?. J Am Coll Cardiol. 2003, 41: 105-112.CrossRefPubMed
9.
go back to reference de Silva R, Rigby AS, Witte KK, et al: Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. Am J Cardiol. 2006, 98: 391-398. 10.1016/j.amjcard.2006.01.107.CrossRefPubMed de Silva R, Rigby AS, Witte KK, et al: Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. Am J Cardiol. 2006, 98: 391-398. 10.1016/j.amjcard.2006.01.107.CrossRefPubMed
10.
go back to reference Windram JD, Loh PH, Rigby AS, Hanning I, Clark AL, Cleland JG: Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure. Am Heart J. 2007, 153: 1048-1055. 10.1016/j.ahj.2007.03.044.CrossRefPubMed Windram JD, Loh PH, Rigby AS, Hanning I, Clark AL, Cleland JG: Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure. Am Heart J. 2007, 153: 1048-1055. 10.1016/j.ahj.2007.03.044.CrossRefPubMed
11.
go back to reference Mullens W, Abrahams Z, Francis GS, et al: Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009, 53: 589-596. 10.1016/j.jacc.2008.05.068.CrossRefPubMedPubMedCentral Mullens W, Abrahams Z, Francis GS, et al: Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009, 53: 589-596. 10.1016/j.jacc.2008.05.068.CrossRefPubMedPubMedCentral
12.
go back to reference Cody RJ, Ljungman S, Covit AB, et al: Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int. 1988, 34: 361-367. 10.1038/ki.1988.189.CrossRefPubMed Cody RJ, Ljungman S, Covit AB, et al: Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int. 1988, 34: 361-367. 10.1038/ki.1988.189.CrossRefPubMed
13.
go back to reference Assomull RG, Prasad SK, Lyne J, et al: Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006, 48: 1977-1985. 10.1016/j.jacc.2006.07.049.CrossRefPubMed Assomull RG, Prasad SK, Lyne J, et al: Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006, 48: 1977-1985. 10.1016/j.jacc.2006.07.049.CrossRefPubMed
14.
go back to reference Smilde TD, Hillege HL, Navis G, Boomsma F, de Zeeuw D, van Veldhuisen DJ: Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. Am Heart J. 2004, 148: 165-172. 10.1016/j.ahj.2004.02.007.CrossRefPubMed Smilde TD, Hillege HL, Navis G, Boomsma F, de Zeeuw D, van Veldhuisen DJ: Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. Am Heart J. 2004, 148: 165-172. 10.1016/j.ahj.2004.02.007.CrossRefPubMed
15.
go back to reference McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW: Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation. 2004, 109: 1004-1009. 10.1161/01.CIR.0000116764.53225.A9.CrossRefPubMed McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW: Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation. 2004, 109: 1004-1009. 10.1161/01.CIR.0000116764.53225.A9.CrossRefPubMed
16.
go back to reference Jackson CE, Solomon SD, Gerstein HC, CHARM Investigators and Committees, et al: Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet. 2009, 374: 543-550. 10.1016/S0140-6736(09)61378-7.CrossRefPubMed Jackson CE, Solomon SD, Gerstein HC, CHARM Investigators and Committees, et al: Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet. 2009, 374: 543-550. 10.1016/S0140-6736(09)61378-7.CrossRefPubMed
17.
go back to reference Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL: Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009, 53: 582-588. 10.1016/j.jacc.2008.08.080.CrossRefPubMed Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL: Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009, 53: 582-588. 10.1016/j.jacc.2008.08.080.CrossRefPubMed
18.
go back to reference Smith GD, Phillips AN: Confounding in epidemiological studies: why “independent” effects may not be all they seem. BMJ. 1992, 305: 757-759. 10.1136/bmj.305.6856.757.CrossRefPubMedPubMedCentral Smith GD, Phillips AN: Confounding in epidemiological studies: why “independent” effects may not be all they seem. BMJ. 1992, 305: 757-759. 10.1136/bmj.305.6856.757.CrossRefPubMedPubMedCentral
19.
go back to reference Foley RN, Parfrey PS, Harnett JD, et al: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995, 47: 186-192. 10.1038/ki.1995.22.CrossRefPubMed Foley RN, Parfrey PS, Harnett JD, et al: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995, 47: 186-192. 10.1038/ki.1995.22.CrossRefPubMed
20.
go back to reference Torp-Pedersen C, Køber L, Carlsen JE, et al: A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure. Eur J Heart Fail. 2008, 10: 89-95. 10.1016/j.ejheart.2007.10.012.CrossRefPubMed Torp-Pedersen C, Køber L, Carlsen JE, et al: A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure. Eur J Heart Fail. 2008, 10: 89-95. 10.1016/j.ejheart.2007.10.012.CrossRefPubMed
21.
go back to reference Akkan D, Kjaergaard J, Møller JE, Hassager C, Torp-Pedersen C, Køber L, EchoCardiography and Heart Outcome Study (ECHOS) investigators: Prognostic importance of a short deceleration time in symptomatic congestive heart failure. Eur J Heart Fail. 2008, 10: 689-695. 10.1016/j.ejheart.2008.05.007.CrossRefPubMed Akkan D, Kjaergaard J, Møller JE, Hassager C, Torp-Pedersen C, Køber L, EchoCardiography and Heart Outcome Study (ECHOS) investigators: Prognostic importance of a short deceleration time in symptomatic congestive heart failure. Eur J Heart Fail. 2008, 10: 689-695. 10.1016/j.ejheart.2008.05.007.CrossRefPubMed
22.
go back to reference Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL: Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation. 2006, 114: 1572-1580. 10.1161/CIRCULATIONAHA.105.610642.CrossRefPubMed Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL: Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation. 2006, 114: 1572-1580. 10.1161/CIRCULATIONAHA.105.610642.CrossRefPubMed
23.
go back to reference Bruch C, Reinecke H, Rothenburger M, Scheld HH, Whalley GA, Stypmann J, Breithardt G, Wichter T, Gradaus R: Transmitral flow patterns and the presence of chronic kidney disease provide independent and incremental prognostic information in patients with heart failure and systolic dysfunction. J Am Soc Echocardiogr. 2007, 20: 989-997. 10.1016/j.echo.2007.01.013.CrossRefPubMed Bruch C, Reinecke H, Rothenburger M, Scheld HH, Whalley GA, Stypmann J, Breithardt G, Wichter T, Gradaus R: Transmitral flow patterns and the presence of chronic kidney disease provide independent and incremental prognostic information in patients with heart failure and systolic dysfunction. J Am Soc Echocardiogr. 2007, 20: 989-997. 10.1016/j.echo.2007.01.013.CrossRefPubMed
24.
go back to reference Aurigemma GP, Zile MR, Gaasch WH: Lack of relationship between Doppler indices of diastolic function and left ventricular pressure transients in patients with definite diastolic heart failure. Am Heart J. 2004, 148: E12-CrossRefPubMed Aurigemma GP, Zile MR, Gaasch WH: Lack of relationship between Doppler indices of diastolic function and left ventricular pressure transients in patients with definite diastolic heart failure. Am Heart J. 2004, 148: E12-CrossRefPubMed
25.
go back to reference Packer M: Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure. Circulation. 1990, 81: 78-86. 10.1161/01.CIR.81.1.78.CrossRef Packer M: Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure. Circulation. 1990, 81: 78-86. 10.1161/01.CIR.81.1.78.CrossRef
26.
go back to reference Costanzo MR, Guglin ME, Saltzberg MT, UNLOAD Trial Investigators, et al: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007, 49: 675-683. 10.1016/j.jacc.2006.07.073.CrossRefPubMed Costanzo MR, Guglin ME, Saltzberg MT, UNLOAD Trial Investigators, et al: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007, 49: 675-683. 10.1016/j.jacc.2006.07.073.CrossRefPubMed
27.
go back to reference Massie BM, O'Connor CM, Metra M, et al: PROTECT Investigators and Committees. N Engl J Med. 2010, 363: 1419-28. 10.1056/NEJMoa0912613.CrossRefPubMed Massie BM, O'Connor CM, Metra M, et al: PROTECT Investigators and Committees. N Engl J Med. 2010, 363: 1419-28. 10.1056/NEJMoa0912613.CrossRefPubMed
28.
go back to reference Chow SL, Peng JT, Okamoto MP, Heywood JT: Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients. Ann Pharmacother. 2007, 41: 556-561. 10.1345/aph.1H589.CrossRefPubMed Chow SL, Peng JT, Okamoto MP, Heywood JT: Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients. Ann Pharmacother. 2007, 41: 556-561. 10.1345/aph.1H589.CrossRefPubMed
29.
go back to reference de Silva R, Nikitin NP, Witte KK, et al: Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure. Eur J Heart Fail. 2007, 9: 415-423. 10.1016/j.ejheart.2006.10.003.CrossRefPubMed de Silva R, Nikitin NP, Witte KK, et al: Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure. Eur J Heart Fail. 2007, 9: 415-423. 10.1016/j.ejheart.2006.10.003.CrossRefPubMed
30.
go back to reference Boerrigter G, Costello-Boerrigter LC, Abraham WT, et al: Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate. J Card Fail. 2008, 14: 539-546. 10.1016/j.cardfail.2008.03.009.CrossRefPubMedPubMedCentral Boerrigter G, Costello-Boerrigter LC, Abraham WT, et al: Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate. J Card Fail. 2008, 14: 539-546. 10.1016/j.cardfail.2008.03.009.CrossRefPubMedPubMedCentral
31.
go back to reference Jose P, Skali H, Anavekar N, Tomson C, et al: Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol. 2006, 17: 2886-2891. 10.1681/ASN.2006010063.CrossRefPubMed Jose P, Skali H, Anavekar N, Tomson C, et al: Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol. 2006, 17: 2886-2891. 10.1681/ASN.2006010063.CrossRefPubMed
32.
go back to reference Hillege HL, van Gilst WH, van Veldhuisen DJ, et al: CATS randomized trial. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J. 2003, 24: 412-420.CrossRefPubMed Hillege HL, van Gilst WH, van Veldhuisen DJ, et al: CATS randomized trial. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J. 2003, 24: 412-420.CrossRefPubMed
33.
go back to reference McMurray JJ, Ostergren J, Swedberg K, CHARM Investigators and Committees, et al: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-added trial. Lancet. 2003, 362: 767-771. 10.1016/S0140-6736(03)14283-3.CrossRefPubMed McMurray JJ, Ostergren J, Swedberg K, CHARM Investigators and Committees, et al: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-added trial. Lancet. 2003, 362: 767-771. 10.1016/S0140-6736(03)14283-3.CrossRefPubMed
34.
go back to reference Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001, 345: 1667-1675. 10.1056/NEJMoa010713.CrossRefPubMed Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001, 345: 1667-1675. 10.1056/NEJMoa010713.CrossRefPubMed
35.
go back to reference Pfeffer MA, McMurray JJ, Velazquez EJ, Valsartan in Acute Myocardial Infarction Trial Investigators, et al: Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003, 349: 1893-1906. 10.1056/NEJMoa032292.CrossRefPubMed Pfeffer MA, McMurray JJ, Velazquez EJ, Valsartan in Acute Myocardial Infarction Trial Investigators, et al: Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003, 349: 1893-1906. 10.1056/NEJMoa032292.CrossRefPubMed
36.
go back to reference van de Wal RM, Asselbergs FW, Plokker HW, et al: High prevalence of microalbuminuria in chronic heart failure patients. J Card Fail. 2005, 11: 602-606. 10.1016/j.cardfail.2005.05.007.CrossRefPubMed van de Wal RM, Asselbergs FW, Plokker HW, et al: High prevalence of microalbuminuria in chronic heart failure patients. J Card Fail. 2005, 11: 602-606. 10.1016/j.cardfail.2005.05.007.CrossRefPubMed
37.
go back to reference Jose P, Tomson C, Skali H, et al: Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction. J Am Coll Cardiol. 2006, 47: 1725-1727. 10.1016/j.jacc.2006.01.047.CrossRefPubMed Jose P, Tomson C, Skali H, et al: Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction. J Am Coll Cardiol. 2006, 47: 1725-1727. 10.1016/j.jacc.2006.01.047.CrossRefPubMed
38.
go back to reference Møller JE, Whalley GA, Dini FL, Meta-Analysis Research Group in Echocardiography (MeRGE) AMI Collaborators, et al: Independent prognostic importance of a restrictive left ventricular filling pattern after myocardial infarction: an individual patient meta-analysis: meta-analysis research group in echocardiography acute myocardial infarction. Circulation. 2008, 117: 2591-2598.CrossRefPubMed Møller JE, Whalley GA, Dini FL, Meta-Analysis Research Group in Echocardiography (MeRGE) AMI Collaborators, et al: Independent prognostic importance of a restrictive left ventricular filling pattern after myocardial infarction: an individual patient meta-analysis: meta-analysis research group in echocardiography acute myocardial infarction. Circulation. 2008, 117: 2591-2598.CrossRefPubMed
39.
go back to reference Meta-analysis Research Group in Echocardiography (MeRGE) Heart Failure Collaborators: Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: an individual patient meta-analysis. Eur J Heart Fail. 2008, 10: 786-792.CrossRef Meta-analysis Research Group in Echocardiography (MeRGE) Heart Failure Collaborators: Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: an individual patient meta-analysis. Eur J Heart Fail. 2008, 10: 786-792.CrossRef
40.
go back to reference Solomon SD, Stevenson LW: Recalibrating the barometer: is it time to take a critical look at noninvasive approaches to measuring filling pressures?. Circulation. 2009, 119: 13-15. 10.1161/CIRCULATIONAHA.108.823591.CrossRefPubMed Solomon SD, Stevenson LW: Recalibrating the barometer: is it time to take a critical look at noninvasive approaches to measuring filling pressures?. Circulation. 2009, 119: 13-15. 10.1161/CIRCULATIONAHA.108.823591.CrossRefPubMed
41.
go back to reference Nielsen OW, Køber L, Torp-Pedersen C: Heart failure with preserved ejection fraction: dangerous, elusive, and difficult. Eur Heart J. 2008, 29: 285-287. 10.1093/eurheartj/ehm597.CrossRefPubMed Nielsen OW, Køber L, Torp-Pedersen C: Heart failure with preserved ejection fraction: dangerous, elusive, and difficult. Eur Heart J. 2008, 29: 285-287. 10.1093/eurheartj/ehm597.CrossRefPubMed
Metadata
Title
Renal dysfunction, restrictive left ventricular filling pattern and mortality risk in patients admitted with heart failure: a 7-year follow-up study
Authors
Morten Schou
Jesper Kjaergaard
Christian Torp-Pedersen
Christian Hassager
Finn Gustafsson
Dilek Akkan
Jacob E Moller
Lars Kober
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-267

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.